Fifty-seven patients with chronic renal failure (CRF) of diverse etiology entered a prospective, randomized study to evaluate the effect of a low protein diet on the progression rate of CRF. All patients were followed for a control period of 12 or 24 months before randomization into two groups, one permitted unrestricted protein intake and the other prescribed a diet containing 0.4 g/kg body wt/day of protein and 0.1 g/kg body wt/day of essential amino acids, (LPD + EAA). During both the control and study periods, patients were clinically evaluated and had serum biochemistry and 24-hour clearance of creatinine, urea and protein excretion checked monthly. The 51Cr-EDTA clearance (plasma slope and urinary clearance) was determined every third month. The progression of renal failure was evaluated from the regressions of the reciprocal of serum creatinine (SCr-1), creatinine clearance and urinary 51Cr-EDTA clearance against time. Having defined criteria for progression, only patients in whom renal failure had progressed over 12 or 24 months were randomized. In 28 patients, data were available, permitting a comparison of the progression of renal failure (estimated from regression of SCr-1 and of creatinine clearance against time) during the retrospective and prospective periods. There was a significant correlation between the change in progression rate and the change in mean arterial pressure, a relationship which was also present in patients with mild hypertension or those with blood pressure within the "normal" range. The urinary protein excretion also correlated with the change in mean arterial pressure.(ABSTRACT TRUNCATED AT 250 WORDS)
Download full-text PDF |
Source |
---|
J Nephrol
January 2025
Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
Background: Autosomal Dominant Polycystic Kidney Disease (ADPKD) represents the most common monogenic cause of kidney failure. While identifying genetic variants predicts disease progression, characterization of recently described ADPKD-like variants is limited. We explored disease progression and genetic spectrum of genetically-confirmed ADPKD families with PKD1 and non-PKD1 variants.
View Article and Find Full Text PDFJ Pediatr Urol
January 2025
Division of Pediatric Urology, Department of Urology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, PA, USA.
Introduction: A significant portion of posterior urethral valve patients continue to progress to end stage renal disease despite improvements in medical care. Socioeconomic status has been connected to various healthcare outcomes but has not been evaluated in relation to longitudinal outcomes of posterior urethral valves.
Objective: To evaluate the effect of socioeconomic status on the progression to renal failure among patients with posterior urethral valves.
JACC Clin Electrophysiol
January 2025
Cardioangiologisches Centrum Bethanien, Agaplesion Markus-Krankenhaus, Frankfurt am Main, Germany.
Background: The net benefit of oral anticoagulation in patients with end-stage renal disease on hemodialysis (HD) is uncertain. In recent years, left atrial appendage closure (LAAC) has emerged as an alternative to oral anticoagulation; however, there is scant evidence of LAAC in patients on HD.
Objectives: This study aimed to assess the feasibility and safety of LAAC in patients on HD.
Objectives: This study aimed to develop a prediction model for the detection of early sepsis-associated acute kidney injury (SA-AKI), which is defined as AKI diagnosed within 48 hours of a sepsis diagnosis.
Design: A retrospective study design was employed. It is not linked to a clinical trial.
BMJ Open
January 2025
Deakin Health Economics, Institute for Health Transformation, Deakin University, Melbourne, Victoria, Australia.
Objective: To assess the prevalence and trends of chronic kidney disease (CKD) in Western Australia (WA) from 2010 to 2020 using linked pathology data.
Design: A retrospective observational cohort study using linked de-identified data from WA pathology providers, hospital morbidity records and mortality records.
Setting: A Western Australian population-based study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!